Stock Track | Treace Medical Concepts (TMCI) Plummets 5.04% in Friday's Intraday Session on Concern Over Future Growth Prospects

Stock Track02-28

Treace Medical Concepts, Inc. (TMCI) stock plummeted 5.04% in Friday's intraday trading session after the company's latest earnings call raised concerns over its future growth prospects.

The medical device company reported strong fourth-quarter results, with revenue growing 10.4% year-over-year to $68.7 million, driven by increased adoption of its newer technologies and an increase in active surgeons. However, the company's guidance for 2025 revenue and profitability fell short of expectations.

Treace Medical expects revenue growth of just 7% to 10% in 2025, with revenue ranging from $224 million to $230 million. The company also guided for breakeven adjusted EBITDA for the full year, which some analysts viewed as underwhelming given the company's focus on profitability and expense management.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1129676811?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-02-28 22:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129676811","market":"hk","top_or_hot":-1,"title":"Stock Track | Treace Medical Concepts (TMCI) Plummets 5.04% in Friday's Intraday Session on Concern Over Future Growth Prospects","media":"Stock Track","content":"<p>Treace Medical Concepts, Inc. (TMCI) stock plummeted 5.04% in Friday's intraday trading session after the company's latest earnings call raised concerns over its future growth prospects.</p>\n\n<p>The medical device company reported strong fourth-quarter results, with revenue growing 10.4% year-over-year to $68.7 million, driven by increased adoption of its newer technologies and an increase in active surgeons. However, the company's guidance for 2025 revenue and profitability fell short of expectations.</p>\n\n<p>Treace Medical expects revenue growth of just 7% to 10% in 2025, with revenue ranging from $224 million to $230 million. The company also guided for breakeven adjusted EBITDA for the full year, which some analysts viewed as underwhelming given the company's focus on profitability and expense management.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Treace Medical Concepts (TMCI) Plummets 5.04% in Friday's Intraday Session on Concern Over Future Growth Prospects</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Treace Medical Concepts (TMCI) Plummets 5.04% in Friday's Intraday Session on Concern Over Future Growth Prospects\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-28 22:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Treace Medical Concepts, Inc. (TMCI) stock plummeted 5.04% in Friday's intraday trading session after the company's latest earnings call raised concerns over its future growth prospects.</p>\n\n<p>The medical device company reported strong fourth-quarter results, with revenue growing 10.4% year-over-year to $68.7 million, driven by increased adoption of its newer technologies and an increase in active surgeons. However, the company's guidance for 2025 revenue and profitability fell short of expectations.</p>\n\n<p>Treace Medical expects revenue growth of just 7% to 10% in 2025, with revenue ranging from $224 million to $230 million. The company also guided for breakeven adjusted EBITDA for the full year, which some analysts viewed as underwhelming given the company's focus on profitability and expense management.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"","article_id":"1129676811","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129676811","pubTimestamp":1740753860,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Treace Medical Concepts, Inc.  stock plummeted 5.04% in Friday's intraday trading session after the company's latest earnings call raised concerns over its future growth prospects.The medical device company reported strong fourth-quarter results, with revenue growing 10.4% year-over-year to $68.7 million, driven by increased adoption of its newer technologies and an increase in active surgeons. However, the company's guidance for 2025 revenue and profitability fell short of expectations.Treace M","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"由于对未来增长前景的担忧，Treace Medical Concepts(TMCI)周五盘中暴跌5.04%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMCI":1},"content_text":"Treace Medical Concepts, Inc. (TMCI) stock plummeted 5.04% in Friday's intraday trading session after the company's latest earnings call raised concerns over its future growth prospects.\nThe medical device company reported strong fourth-quarter results, with revenue growing 10.4% year-over-year to $68.7 million, driven by increased adoption of its newer technologies and an increase in active surgeons. However, the company's guidance for 2025 revenue and profitability fell short of expectations.\nTreace Medical expects revenue growth of just 7% to 10% in 2025, with revenue ranging from $224 million to $230 million. The company also guided for breakeven adjusted EBITDA for the full year, which some analysts viewed as underwhelming given the company's focus on profitability and expense management.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1129676811"}